117 件 ・ 関連度順
概要と使いどころ
Assesses potential suppliers against defined commercial, operational, and compliance requirements. Use when the user provides supplier records plus sourcing requirements and wants a consistent shortlist with strengths and risks.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates potential channel, integration, affiliate, or strategic partners. Use when the user provides partner profiles plus partnership goals and wants fit scoring, partnership type, and outreach priority.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates candidate profiles against a job description and hiring criteria. Use when the user provides candidate profiles plus a role definition and wants consistent screening, matched requirements, and an interview recommendation.
日本語の概要は準備中です。原文の説明を表示しています。
Qualify Windows desktop installers in GitHub Actions and promote verified Windows/macOS assets from one frozen SHA. Use for cloud packaging, installer failures, or GitHub Release publication; not local packaging or macOS qualification.
日本語の概要は準備中です。原文の説明を表示しています。
Drafts an account plan from the CRM notes, emails, meeting notes and contracts the user provides: situation, stakeholder map, opportunities as recorded, risks, open commitments and proposed next actions, every line traced to a source and gaps marked UNKNOWN. Returns a DRAFT Markdown document in the chat. Use when the user asks to "build an account plan", "refresh the key account plan", "what do we know about this account", "account review for <customer>" or "what should happen next on this account". Do not use for preparing a first call with a prospect, use discovery-call-prep instead; for scoring inbound leads against a rubric use lead-qualification-scorer. Drafts for human review; never approves, authorises or signs off.
日本語の概要は準備中です。原文の説明を表示しています。
Reviews one deal's notes and timeline (CRM opportunity record, activity log, emails, meeting notes, forecast entries) for risk signals such as a single contact thread, no identified budget owner, slipped or missing dates, silence after a proposal, an undefined decision process or a competitor named late, and returns a DRAFT risk register: each signal with the quoted evidence and its date, a severity on a stated scale, and one proposed next action with an owner role for the user to decide on. Use when the user asks to "review the risks on this deal", "why is this opportunity stalling", "is this deal single-threaded", "deal health check before the forecast call" or "what should we do next on <opportunity>". Do not use for a whole-account plan, use account-plan-builder instead; for scoring early leads against a rubric use lead-qualification-scorer. Drafts for human review; never approves, authorises or signs off.
日本語の概要は準備中です。原文の説明を表示しています。
Manage the NV oOS Pro Toolkit CRM — leads, deals, companies, contacts, customers, activities, and support tickets. Covers the complete sales pipeline from lead capture through qualification, deal management, and post-conversion customer tracking with BANT/MEDDIC scoring, activity logging, and workflow automation. Use when working with CRM records, managing pipeline stages, qualifying leads, creating company profiles, logging calls/emails/meetings, or troubleshooting CRM data issues.
日本語の概要は準備中です。原文の説明を表示しています。
Build qualified prospect lists using an explicit ICP, source provenance, qualification criteria, scoring, enrichment hygiene and outreach-compliance checks.
日本語の概要は準備中です。原文の説明を表示しています。
Calculate the home office deduction using either the simplified method ($5/sq ft, max $1,500) or actual expense method (Form 8829). Covers qualification rules, exclusive-use test, direct vs indirect expenses, and depreciation of home. Trigger on "home office deduction", "Form 8829", "can I deduct my home office", "work from home tax".
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Assemble a Japanese shokumu-keirekisho (career history document) from an experience inventory, choosing between reverse-chronological, chronological, and skills-based layouts, mapping the target posting's requirements to the experiences that can support them, and drafting the summary, work history, skills, and self-PR so that each sentence stays within what its evidence supports and confidential details are abstracted. Use when a user wants to write or rebuild a whole shokumu-keirekisho for a specific posting or as a general version, or wants to decide which experiences to include and in what order; do not use to invent experience, numbers, titles, or qualifications, to predict whether it will pass screening, to fill in a rirekisho form, or to submit it anywhere.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
When the user wants help with revenue operations, lead lifecycle management, or marketing-to-sales handoff processes. Also use when the user mentions 'RevOps,' 'revenue operations,' 'lead scoring,' 'lead routing,' 'MQL,' 'SQL,' 'pipeline stages,' 'deal desk,' 'CRM automation,' 'marketing-to-sales handoff,' 'data hygiene,' 'leads aren't getting to sales,' 'pipeline management,' 'lead qualification,' or 'when should marketing hand off to sales.' Use this for anything involving the systems and processes that connect marketing to revenue. For cold outreach emails, see cold-email. For email drip campaigns, see email-sequence. For pricing decisions, see pricing-strategy.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Use this skill when the user asks about CDL driver medical certification — 49 CFR 391.41-49 medical qualifications, medical examiner's certificate (Long Form 5876 + Short Form 5875), National Registry of Certified Medical Examiners (NRCME), medical restrictions, federal disqualifying conditions, exemption programs (vision, diabetes, hearing), the FMCSA Medical Examiner's Handbook, or what to do when a driver's medical cert is downgraded. Cite specific 49 CFR 391 sections.
日本語の概要は準備中です。原文の説明を表示しています。
Use this skill to understand which MVR violations disqualify a driver under federal rules. Covers § 391.15 disqualifications, varying state rules, and CSA impact.
日本語の概要は準備中です。原文の説明を表示しています。
Use this skill when selecting an MRO for drug testing program oversight. Covers MRO qualifications under Part 40, what the MRO does, and how to evaluate MRO services.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a carrier (asset-based, brokerage, or 3PL) asks how to respond to a shipper RFP / RFQ — bid packaging, lane analysis, rate strategy, SOPs/SOWs, qualifications response, insurance compliance, EDI requirements, and how to win competitive bids without leaving margin on the table.
日本語の概要は準備中です。原文の説明を表示しています。
Use this skill when re-hiring a driver who has been away from CMV operation for 1+ years. Covers re-qualification, refresh of medical and MVR, and whether prior employer inquiries restart.
日本語の概要は準備中です。原文の説明を表示しています。
Strategic account planning and execution for enterprise deals. Use when planning complex sales cycles, managing multiple stakeholders, applying MEDDICC qualification, tracking deal health, or building mutual action plans. Includes the "stale MAP equals dead deal" pattern.
日本語の概要は準備中です。原文の説明を表示しています。
Score raw leads as HOT/WARM/COOL based on config-driven weights from agency.config.json
日本語の概要は準備中です。原文の説明を表示しています。